| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BBR.2008.03.018 |
| P698 | PubMed publication ID | 18453008 |
| P2093 | author name string | Joanna C Neill | |
| Shikha Snigdha | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 26-31 | |
| P577 | publication date | 2008-03-22 | |
| P1433 | published in | Behavioural Brain Research | Q3619047 |
| P1476 | title | Improvement of phencyclidine-induced social behaviour deficits in rats: involvement of 5-HT1A receptors | |
| P478 | volume | 191 |
| Q47739946 | Analysis of sociability and preference for social novelty in the acute and subchronic phencyclidine rat. |
| Q38248566 | Antipsychotic treatment modulates glutamate transport and NMDA receptor expression |
| Q38680970 | Anxiety does not contribute to social withdrawal in the subchronic phencyclidine rat model of schizophrenia |
| Q39244947 | Aripiprazole, a Drug that Displays Partial Agonism and Functional Selectivity |
| Q46859633 | Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism |
| Q34169978 | Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties. |
| Q59795807 | Cystine/Glutamate Antiporter and Aripiprazole Compensate NMDA Antagonist-Induced Dysfunction of Thalamocortical L-Glutamatergic Transmission |
| Q36604575 | Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: Possible involvement of the endocannabinoid system |
| Q48732339 | Effect of transient blockade of N-methyl-D-aspartate receptors at neonatal stage on stress-induced lactate metabolism in the medial prefrontal cortex of adult rats: role of 5-HT1A receptor agonism |
| Q47669147 | Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, on cognitive dysfunction and social aversion in rats |
| Q37112450 | Effects of Subchronic Phencyclidine (PCP) Treatment on Social Behaviors, and Operant Discrimination and Reversal Learning in C57BL/6J Mice |
| Q46927168 | Effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: relationship with glutamate release in the medial prefrontal cortex |
| Q34628396 | Effects of chronic oral treatment with aripiprazole on the expression of NMDA receptor subunits and binding sites in rat brain |
| Q28533794 | Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats. |
| Q48288929 | Evaluation of antidepressant and memory-improving efficacy of aripiprazole and fluoxetine in alcohol-preferring rats. |
| Q38444551 | Glutamatergic agents for schizophrenia: current evidence and perspectives |
| Q37315499 | Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines |
| Q50605503 | Influence of aripiprazole on the antidepressant, anxiolytic and cognitive functions of rats. |
| Q45927862 | Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats. |
| Q38128733 | Leading compounds for the validation of animal models of psychopathology |
| Q36979068 | Low doses of the NMDA receptor antagonists, MK-801, PEAQX, and ifenprodil, induces social facilitation in adolescent male rats |
| Q36594948 | New Pharmacotherapy Targeting Cognitive Dysfunction of Schizophrenia via Modulation of GABA Neuronal Function |
| Q51030175 | PD168077, a D(4) receptor agonist, reverses object recognition deficits in rats: potential role for D(4) receptor mechanisms in improving cognitive dysfunction in schizophrenia. |
| Q39998926 | Potential application as screening and drug designing tools of cytoarchitectural deficiencies present in three animal models of schizophrenia |
| Q37709577 | Preclinical behavioral models for predicting antipsychotic activity. |
| Q45921170 | Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat. |
| Q90395463 | Selective adrenergic alpha2C receptor antagonist ameliorates acute phencyclidine-induced schizophrenia-like social interaction deficits in rats |
| Q35009210 | Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms |
| Q48248565 | Social interaction rescues memory deficit in an animal model of Alzheimer's disease by increasing BDNF-dependent hippocampal neurogenesis. |
| Q46004595 | Subchronic effects of phencyclidine on dopamine and serotonin receptors: implications for schizophrenia. |
| Q37641817 | The effects of an acute challenge with the NMDA receptor antagonists, MK-801, PEAQX, and ifenprodil, on social inhibition in adolescent and adult male rats |
| Q35222750 | The hippocampo-prefrontal pathway: a possible therapeutic target for negative and cognitive symptoms of schizophrenia |
| Q35111468 | The phytocannabinoid, Δ⁹-tetrahydrocannabivarin, can act through 5-HT₁A receptors to produce antipsychotic effects. |
| Q38057380 | The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania. |
| Q50974329 | The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats. |
| Q38149953 | Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia |
| Q28084069 | Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism |
Search more.